logo

BBLG

Bone Biologics·NASDAQ
--
--(--)
--
--(--)

BBLG fundamentals

Bone Biologics (BBLG) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.33 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-1.33
--
Report date
Aug 14, 2025
EPS
Q1,2022
Q3,2022
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-100.8-81.12-29.28-35.34-7.86-0.32-1.33
Forecast
-288-172.8-81.12-29.28-282.72-7.86-4.02-3.6-3.54-3.24-0.58
Surprise
+65.00%
0.00%
0.00%
0.00%
+87.50%
0.00%
0.00%
0.00%
0.00%
+90.12%
-129.31%
Revenue
Q1,2022
Q3,2022
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
0--0000------00
Forecast
00000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call